Form 4 Tracker
Kiniksa Pharmaceuticals International, plc
KNSA

43 insider filings · Latest: Sep 1, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
Oct 20, 2025Oct 20 9:49 PMPatel Sanj K
Proposed Sale
257,969$38.90$10.0M—

View →

Oct 20, 2025Oct 20 9:48 PMMegna Michael R
Proposed Sale
50,490$38.88$2.0M—

View →

Oct 14, 2025Oct 14 8:52 PMTessari Eben
Proposed Sale
12,368$37.66$465.8K—

View →

Sep 29, 2025Sep 29 9:24 PMTessari Eben
Proposed Sale
42,000$38.33$1.6M—

View →

Sep 15, 2025Sep 15 9:20 PMTessari Eben
Proposed Sale
16,400$36.46$598.0K—

View →

Sep 5, 2025Sep 5 8:39 PMTessari Eben
Proposed Sale
13,389$35.66$477.5K—

View →

Sep 4, 2025Sep 4 8:52 PMTessari Eben
Proposed Sale
85,271$35.52$3.0M—

View →

Sep 4, 2025Sep 4 8:51 PMMoat Ross
Proposed Sale
3,523$35.31$124.4K—

View →

Sep 3, 2025Sep 3 8:56 PMTessari Eben
Proposed Sale
15,091$35.50$535.8K—

View →

Sep 3, 2025Sep 3 8:16 PMMegna Michael R
Proposed Sale
11,000$34.84$383.2K—

View →

Aug 18, 2025Aug 18 9:13 PMTessari Eben
Proposed Sale
16,200$33.77$547.1K—

View →

Aug 14, 2025Aug 14 8:36 PMMalley Thomas
Proposed Sale
78,233$33.09$2.6M—

View →

Aug 13, 2025Aug 13 8:24 PMMalley Thomas
Proposed Sale
50,129$33.32$1.7M—

View →

Aug 12, 2025Aug 12 8:54 PMMalley Thomas
Proposed Sale
49,407$32.40$1.6M—

View →

Aug 6, 2025Aug 6 9:37 PMPaolini John F.
Proposed Sale
29,325$32.55$954.5K—

View →

Aug 5, 2025Aug 5 9:23 PMTessari Eben
Proposed Sale
138,614$33.20$4.6M—

View →

Aug 4, 2025Aug 4 8:09 PMRagosa Mark
Proposed Sale
18,889$32.89$621.3K—

View →

Aug 4, 2025Aug 4 8:09 PMMegna Michael R
Proposed Sale
17,000$32.35$549.9K—

View →

Jul 30, 2025Jul 30 8:06 PMKIMBERLY J. POPOVITS
Proposed Sale
64,508$29.90$1.9M—

View →

Jul 14, 2025Jul 14 9:04 PMTessari Eben
Proposed Sale
18,900$28.72$542.9K—

View →

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
Sep 1, 2026Sep 3 8:49 PMMark RagosaCHIEF FINANCIAL OFFICER
Option Exercise
9,104—0(D)

View →

Sep 1, 2026Sep 3 8:49 PMMark RagosaCHIEF FINANCIAL OFFICER
Grant/Award
38,950$79.2831,150(D)

View →

Sep 1, 2026Sep 3 8:48 PMSanj K PatelDirector, CHAIRMAN & CEO
Grant/Award
150,200$79.28120,150(D)

View →

Sep 1, 2026Sep 3 8:48 PMSanj K PatelDirector, CHAIRMAN & CEO
Option Exercise
31,318—0(D)

View →

Sep 1, 2026Sep 3 8:46 PMSanj K PatelDirector, CHAIRMAN & CEO
Grant/Award
150,200$79.28120,150(D)

View →

Sep 1, 2026Sep 3 8:46 PMSanj K PatelDirector, CHAIRMAN & CEO
Option Exercise
31,318—0(D)

View →

Sep 1, 2026Sep 3 8:43 PMJohn F. PaoliniCHIEF MEDICAL OFFICER
Option Exercise
8,328—0(D)

View →

Sep 1, 2026Sep 3 8:43 PMJohn F. PaoliniCHIEF MEDICAL OFFICER
Grant/Award
33,450$79.2826,750(D)

View →

Sep 1, 2026Sep 3 8:41 PMRoss MoatCHIEF OPERATING OFFICER
Option Exercise
8,285—0(D)

View →

Sep 1, 2026Sep 3 8:41 PMRoss MoatCHIEF OPERATING OFFICER
Grant/Award
46,200$79.2836,950(D)

View →

Sep 1, 2026Sep 3 8:40 PMMichael R MegnaCHIEF ACCOUNTING OFFICER
Grant/Award
18,250$79.2814,600(D)

View →

Sep 1, 2026Sep 3 8:40 PMMichael R MegnaCHIEF ACCOUNTING OFFICER
Option Exercise
11,496—0(D)

View →

Aug 1, 2026Aug 4 8:40 PMRichard S LevyDirector
Grant/Award
403—403(D)

View →

Aug 1, 2026Aug 4 8:40 PMRichard S LevyDirector
Option Exercise
403—0(D)

View →

Jul 1, 2026Jul 6 8:42 PMDhiraj H MalkaniCHIEF STRATEGY OFFICER
Grant/Award
103,459$62.880(D)

View →

May 29, 2026Jun 2 8:52 PMBarry D QuartDirector
Option Exercise
2,799—0(D)

View →

May 29, 2026Jun 2 8:52 PMBarry D QuartDirector
Grant/Award
14,184$48.382,026(D)

View →

May 29, 2026Jun 2 8:51 PMKimberly J PopovitsDirector
Option Exercise
2,799—0(D)

View →

May 29, 2026Jun 2 8:51 PMKimberly J PopovitsDirector
Grant/Award
14,184$48.382,026(D)

View →

Jun 1, 2026Jun 2 8:50 PMSanj K PatelDirector, CHAIRMAN & CEO
Conversion
900,000—626,160(I)

View →

Page 1 of 4

Next →